scholarly journals Postoperative Outcomes of Cyanoacrylate Embolization Compared to Radiofrequency Ablation for Varicose Veins

2021 ◽  
Vol 32 (3) ◽  
pp. 331-335
Author(s):  
Kohei Hachiro ◽  
Takeshi Kinoshita ◽  
Shoichiro Shiraishi ◽  
Atsuyuki Wada ◽  
Tomoaki Suzuki
2016 ◽  
Vol 50 (1) ◽  
pp. 47-51 ◽  
Author(s):  
Orhan Bozoglan ◽  
Bulent Mese ◽  
Erdinc Eroglu ◽  
Mustafa Bilge Erdogan ◽  
Kemalettin Erdem ◽  
...  

2009 ◽  
Vol 24 (1_suppl) ◽  
pp. 42-49 ◽  
Author(s):  
M S Gohel ◽  
A H Davies

In recent years, minimally invasive endovenous treatments have gained popularity in the treatment of superficial venous reflux. The perceived advantages of endovenous therapy include reduced pain, high vein occlusion rates, and early return to work and normal activities. Endovenous radiofrequency ablation (RFA) involves the delivery of thermal energy from a bipolar catheter to the venous segment to be treated. This technique has been available since 1998 and numerous devices and catheters are now produced. Numerous prospective and randomized studies have compared the effectiveness of RFA with traditional and endovenous procedures. In this article, the available evidence for clinical effectiveness, quality of life and cost gains following endovenous RFA is summarized. The scientific principles behind RFA and technical procedural considerations are discussed and standards of care for the delivery of endovenous RFA are proposed.


2018 ◽  
Vol 61 (2) ◽  
pp. 128-138 ◽  
Author(s):  
Thomas G. Poder ◽  
Jean-François Fisette ◽  
Suzanne K. Bédard ◽  
Marc-Antoine Despatis

2020 ◽  
Vol 7 ◽  
Author(s):  
Insoo Park ◽  
Sun-Cheol Park

Background: Radiofrequency ablation (RFA) has shown faster recovery and lower pain scores compared to Endovenous laser ablation (EVLA) for treatment of varicose veins. However, a comparison of 1,940-nm EVLA and RFA has not been reported. This study compared short-term outcomes using 1,940-nm EVLA and RFA for varicose veins.Methods: Between April 2018 and June 2018, 43 patients (83 incompetent saphenous veins) were treated with 1,940-nm EVLA and 37 patients (64 incompetent saphenous veins) with RFA. Follow-up duplex was checked at 1 month and 3 months.Results: Baseline characteristics showed no significant differences between both groups except for age. Pain scores at 6 h, and at 1, 10, and 30 days after treatment showed no differences. Complications and time to return to normal activity showed no differences. The 100% closure rate was checked in both groups at 1 month and 3 months follow-up.Conclusion: Short-term outcomes showed no significant differences between 1,940-nm EVLA and RFA treatment.


Sign in / Sign up

Export Citation Format

Share Document